2,531
Views
6
CrossRef citations to date
0
Altmetric
Minireview

Imatinib a Tyrosine Kinase Inhibitor: a potential treatment for SARS- COV-2 induced pneumonia

ORCID Icon &
Pages 68-72 | Received 07 Apr 2020, Accepted 01 Jun 2020, Published online: 18 Jun 2020

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.